Squarepoint’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-200,912
Closed -$98.4K 4379
2023
Q2
$98.4K Buy
+200,912
New +$164K ﹤0.01% 3362
2023
Q1
Sell
-52,444
Closed -$141K 3967
2022
Q4
$141K Buy
+52,444
New +$138K ﹤0.01% 2891
2022
Q2
Sell
-81,170
Closed -$577K 3558
2022
Q1
$577K Buy
81,170
+60,787
+298% +$503K ﹤0.01% 1926
2021
Q4
$371K Sell
20,383
-52,025
-72% -$1.12M ﹤0.01% 2336
2021
Q3
$1.42M Buy
+72,408
New +$2.75M ﹤0.01% 1371

Other funds holding CELL

Squarepoint's CELL Position: Q3 2023 in Review

Squarepoint sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 200,912 shares — an estimated $98.4K sold.

Squarepoint first reported a position in CELL in Q3 2021 and held it in 5 quarters. The position peaked at $1.42M in Q3 2021. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • Squarepoint reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Squarepoint sold 200,912 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $98.4K.
  • Squarepoint first reported a position in PhenomeX Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • Squarepoint's PhenomeX Inc. Common Stock position peaked at $1.42M in Q3 2021.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Squarepoint's 13F filing for Q3 2023, filed 14 Nov 2023.